Statistics at a Glance
At a Glance
Estimated New Cases in 2020 8,480
% of All New Cancer Cases 0.5%
Estimated Deaths in 2020 970
% of All Cancer Deaths 0.2%
|Year||Rate of New Cases — SEER 9||Rate of New Cases — SEER 13||Death Rate — U.S.||5-Year Relative Survival — SEER 9|
|Observed||Modeled Trend||Observed||Modeled Trend||Observed||Modeled Trend||Observed||Modeled Trend|
New cases come from SEER 13. Deaths come from U.S. Mortality.
All Races, Both Sexes. Rates are Age-Adjusted.
Modeled trend lines were calculated from the underlying rates using the Joinpoint Trend Analysis Software.
New cases are also referred to as incident cases in other publications. Rates of new cases are also referred to as incidence rates.
Rate of New Cases and Deaths per 100,000: The rate of new cases of Hodgkin lymphoma was 2.6 per 100,000 men and women per year. The death rate was 0.3 per 100,000 men and women per year. These rates are age-adjusted and based on 2013–2017 cases and deaths.
Lifetime Risk of Developing Cancer: Approximately 0.2 percent of men and women will be diagnosed with Hodgkin lymphoma at some point during their lifetime, based on 2015–2017 data.
Prevalence of This Cancer: In 2017, there were an estimated 215,531 people living with Hodgkin lymphoma in the United States.
How Many People Survive 5 Years Or More after Being Diagnosed with Hodgkin Lymphoma?
Relative survival is an estimate of the percentage of patients who would be expected to survive the effects of their cancer. It excludes the risk of dying from other causes. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.
Based on data from SEER 18 2010–2016. Gray figures represent those who have died from Hodgkin lymphoma. Green figures represent those who have survived 5 years or more.
Survival by Stage
Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. For Hodgkin lymphoma, 14.2% are diagnosed at stage I. The 5-year relative survival for stage I Hodgkin lymphoma is 91.3%.
|Stage||Percent of Cases||5-Year Relative Survival|
Confined to Single Region
Involving Mulitple Regions
Spread to Both Sides of Diaphragm
Diffuse or Disseminated Involvement
SEER 18 2010–2016, All Races, Both Sexes by Ann Arbor Stage
New Cases and Deaths
How Common Is This Cancer?
Compared to other cancers, Hodgkin lymphoma is rare.
|Rank||Common Types of Cancer||Estimated New
|1.||Breast Cancer (Female)||276,480||42,170|
|2.||Lung and Bronchus Cancer||228,820||135,720|
|5.||Melanoma of the Skin||100,350||6,850|
|8.||Kidney and Renal Pelvis Cancer||73,750||14,830|
Hodgkin lymphoma represents 0.5% of all new cancer cases in the U.S.
In 2020, it is estimated that there will be 8,480 new cases of Hodgkin lymphoma and an estimated 970 people will die of this disease.
Who Gets This Cancer?
Hodgkin lymphoma is more common among young adults and among men than women. It can occur in both adults and children; however, treatment for adults may be different than treatment for children. Hodgkin lymphoma may also occur in patients who have acquired immunodeficiency syndrome (AIDS); these patients require special treatment. The rate of new cases of Hodgkin lymphoma was 2.6 per 100,000 men and women per year based on 2013–2017 cases, age-adjusted.
|American Indian/Alaska Native||1.2|
|American Indian/Alaska Native||1.3|
SEER 21 2013–2017, Age-Adjusted
|Age Range||Percent of New Cases|
Hodgkin lymphoma is most frequently diagnosed among people aged 20–34.
SEER 21 2013–2017, All Races, Both Sexes
Who Dies From This Cancer?
The death rate was 0.3 per 100,000 men and women per year based on 2013–2017 deaths, age-adjusted.
|American Indian/Alaska Native||Not Shown, <16 cases|
|American Indian/Alaska Native||Not Shown, <16 cases|
U.S. 2013–2017, Age-Adjusted
|Age Range||Percent of Deaths|
The percent of Hodgkin lymphoma deaths is highest among people aged 75–84.
U.S. 2013–2017, All Races, Both Sexes
Trends in Rates
Changes Over Time
Keeping track of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.
Using statistical models for analysis, age-adjusted rates for new Hodgkin lymphoma cases have been falling on average 2.3% each year over the last 10 years. Age-adjusted death rates have been falling on average 4.3% each year over 2008–2017. 5-year relative survival trends are shown below.
Interactive Statistics with SEER*Explorer
- Create custom graphs and tables
- Download data and images
- Share links to results
SEER*Explorer is an interactive website that provides easy access to a wide range of SEER cancer statistics. It provides detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.Explore Additional Hodgkin Lymphoma Statistics
More About This Cancer
Figure: Anatomy of the lymph system, showing the lymph vessels and lymph organs including lymph nodes, tonsils, thymus, spleen, and bone marrow. Lymph (clear fluid) and lymphocytes travel through the lymph vessels and into the lymph nodes where the lymphocytes destroy harmful substances. The lymph enters the blood through a large vein near the heart.
Hodgkin lymphoma is a cancer of the immune system that is marked by the presence of a type of cell called the Reed-Sternberg cell. The two major types of Hodgkin lymphoma are classical Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma. Symptoms include the painless enlargement of lymph nodes, spleen, or other immune tissue. Other symptoms include fever, weight loss, fatigue, or night sweats. Also called Hodgkin disease.
Here are some resources for learning more about Hodgkin lymphoma.
- More about risk factors for Hodgkin lymphoma cancer
- More about symptoms and diagnosis of Hodgkin lymphoma cancer
- More about treatment options for Hodgkin lymphoma cancer
- More about clinical trials
- More about cancer prevention
All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within:
Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2017, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2017/, based on November 2019 SEER data submission, posted to the SEER web site, April 2020.
All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
SEER Cancer Stat Facts: Hodgkin Lymphoma. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/hodg.html
These stat facts focus on population statistics that are based on the U.S. population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse the SEER Cancer Statistics Review. To see statistics for a specific state, go to the State Cancer Profiles.
The statistics presented in these stat facts are based on the most recent data available, most of which can be found in the SEER Cancer Statistics Review. In some cases, different year spans may be used.
Estimates of new cases and deaths for 2020 are projections made by the American Cancer Society (ACS), based on earlier reported data.
Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.